Exelixis

This study tested whether the drug cabozantinib could help control aggressive brain tumors that had returned after initial treatment. It involved 19 people with recurrent grade IV astrocytic tumors and tested four different dosing schedules to find the best balance of effectivene…

This study aimed to see if combining two drugs, cabozantinib and abiraterone, was safe and effective for men with advanced prostate cancer that had spread to their bones and was no longer responding to standard hormone therapy. Participants were assigned to receive different dose…